ARALEZ PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
ARALEZ PHARMACEUTICALS INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $2.91 per share as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2018-05-08
- 2018-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $2.91.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $3.28.
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $3.32.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $3.89.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2018-03-31 | $2.91 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.28 10-Q · filed 2018-05-08 |
| 2017-09-30 | $3.32 10-Q · filed 2017-11-09 |
| 2017-06-30 | $3.89 10-Q · filed 2017-08-09 |
| 2017-03-31 | $4.76 10-Q · filed 2017-05-09 |
| 2016-12-31 | $5.85 10-K · filed 2018-03-14 |
| 2016-09-30 | $5.73 10-Q · filed 2016-11-08 |
| 2016-06-30 | $5.83 10-Q · filed 2016-08-09 |
| 2016-03-31 | $5.85 10-Q · filed 2016-05-10 |
| 2015-12-31 | $8.18 10-K · filed 2017-03-13 |